Logo - springer
Slogan - springer

Biomedical Sciences - Cancer Research | Pathobiology of Cancer Regimen-Related Toxicities

Pathobiology of Cancer Regimen-Related Toxicities

Sonis, Stephen T., Keefe, Dorothy M. (Eds.)

2013, X, 292 p. 30 illus., 23 illus. in color.

Available Formats:

Springer eBooks may be purchased by end-customers only and are sold without copy protection (DRM free). Instead, all eBooks include personalized watermarks. This means you can read the Springer eBooks across numerous devices such as Laptops, eReaders, and tablets.

You can pay for Springer eBooks with Visa, Mastercard, American Express or Paypal.

After the purchase you can directly download the eBook file or read it online in our Springer eBook Reader. Furthermore your eBook will be stored in your MySpringer account. So you can always re-download your eBooks.


(net) price for USA

ISBN 978-1-4614-5438-0

digitally watermarked, no DRM

Included Format: PDF and EPUB

download immediately after purchase

learn more about Springer eBooks

add to marked items


Hardcover version

You can pay for Springer Books with Visa, Mastercard, American Express or Paypal.

Standard shipping is free of charge for individual customers.


(net) price for USA

ISBN 978-1-4614-5437-3

free shipping for individuals worldwide

usually dispatched within 3 to 5 business days

add to marked items

  • Defines the scope, impact and behavior of cancer regimen-related toxicities
  • Discusses the most current thinking around the pathobiology of specific, common, and representative toxicities
  • Discusses the common biological relationships between toxicities, bioinformatical approaches to analysing key and common pathways, and strategies for the development of effective interventions

Toxicities have been consistent undesirable companions of every form of radiation and drug cancer treatment regimens.  In addition to the potential for toxicities to devastate patients’ quality of life, they generate huge incremental financial costs, and sap patients’ ability to tolerate definitive cancer therapy.   And every new drug or biological has come with new side effects.   Historically, regimen-related toxicities were viewed as the inevitable cost of treating cancer.  But this may be about to change.

Discoveries in the past dozen years have painted a new picture of the pathobiology of almost all regimen-related toxicities.  The mechanistic complexities that underlie radiation- and chemotherapy-induced tissue injury or systemic symptoms have been pieced together in an incremental sequence which now provides multiple targets for effective toxicity interventions.

This book brings together, for the first time in a single volume, the most current information regarding both general principles guiding current thinking about the pathogenesis of regimen-related toxicities and the specific biological underpinnings of the most common side effects of cancer therapy.  The contents provide information that is essential to clinicians and basic and translational scientists interested in cancer therapy and its toxicities.

Content Level » Research

Keywords » Bioinformatics - Cancer Research - Pharmacology - Toxicology

Related subjects » Cancer Research - Pharmacology & Toxicology

Table of contents 

Preface.-Epidemiology and outcomes of regimen-related toxicities.- The biological basis for differences in normal tissue response to radiation therapy and strategies to establish predictive assays for individual complication risk.- The bystander effect: Ionizing radiation-induced non-targeted effects: Evidence, mechanism and significance.- The role of genes on the metabolism of chemotherapeutic agents and their impact on toxicity.-  Animal models of regimen-related toxicities.- Nausea and Vomiting.- Mucositis.- Dermatitis and Alopecia.-  Fibrosis.-  Myelosuppression.- Neuropathy.- Fatigue.- Xerostomia.- Osteonecrosis.- Conclusions and therapeutic opportunities.- Index.

Popular Content within this publication 



Read this Book on Springerlink

Services for this book

New Book Alert

Get alerted on new Springer publications in the subject area of Cancer Research.